We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+5.27%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$146B
AUM Growth
+$2.85B
Cap. Flow
-$1.67B
Cap. Flow %
-1.15%
Top 10 Hldgs %
33.08%
Holding
2,546
New
41
Increased
569
Reduced
1,097
Closed
88

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$153M
2
GEV icon
GE Vernova
GEV
+$129M
3
FER icon
Ferrovial N.V. Ordinary Shares
FER
+$61.6M
4
SOLV icon
Solventum
SOLV
+$26.3M
5
MSTR icon
Strategy Inc
MSTR
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 33.83%
2 Healthcare 12.16%
3 Consumer Discretionary 11.34%
4 Communication Services 9.35%
5 Industrials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIC icon
2426
Oric Pharmaceuticals
ORIC
$1.43B
$469K ﹤0.01%
+66,300
New +$593K
TRDA icon
2427
Entrada Therapeutics
TRDA
$276M
$467K ﹤0.01%
32,800
+9,800
+43% +$139K
VTOL icon
2428
Bristow Group
VTOL
$1.37B
$466K ﹤0.01%
13,900
ALGT icon
2429
Allegiant Air
ALGT
$2.35B
$458K ﹤0.01%
9,128
DNTH icon
2430
Dianthus Therapeutics
DNTH
$6.12B
$448K ﹤0.01%
+17,300
New +$416K
ATSG
2431
DELISTED
Air Transport Services Group
ATSG
$447K ﹤0.01%
32,250
CRGX
2432
DELISTED
CARGO Therapeutics
CRGX
$445K ﹤0.01%
27,100
-1,400
-5% -$26.6K
ZNTL icon
2433
Zentalis Pharmaceuticals
ZNTL
$296M
$428K ﹤0.01%
104,700
+7,300
+7% +$81.5K
DGICA icon
2434
Donegal Group Class A
DGICA
$691M
$420K ﹤0.01%
32,600
SMWB icon
2435
Similarweb
SMWB
$726M
$419K ﹤0.01%
53,974
SLSR
2436
Solaris Resources
SLSR
$1.36B
$410K ﹤0.01%
+146,800
New +$505K
JOUT icon
2437
Johnson Outdoors
JOUT
$495M
$406K ﹤0.01%
11,600
OLPX
2438
DELISTED
Olaplex Holdings
OLPX
$397K ﹤0.01%
258,100
MGNX icon
2439
MacroGenics
MGNX
$256M
$390K ﹤0.01%
91,800
SHCO
2440
DELISTED
Soho House & Co
SHCO
$375K ﹤0.01%
70,600
HLLY icon
2441
Holley
HLLY
$372M
$372K ﹤0.01%
104,000
GNE icon
2442
Genie Energy
GNE
$383M
$371K ﹤0.01%
25,400
-12,900
-34% -$196K
EAF icon
2443
GrafTech
EAF
$201M
$368K ﹤0.01%
37,940
-2,550
-6% -$39.2K
OFLX icon
2444
Omega Flex
OFLX
$303M
$359K ﹤0.01%
7,000
LYEL icon
2445
Lyell Immunopharma
LYEL
$362M
$359K ﹤0.01%
12,370
SNCY
2446
DELISTED
Sun Country Airlines
SNCY
$347K ﹤0.01%
27,600
TRML
2447
DELISTED
Tourmaline Bio
TRML
$324K ﹤0.01%
25,200
-6,800
-21% -$109K
ALTG icon
2448
Alta Equipment Group
ALTG
$247M
$310K ﹤0.01%
38,600
SRG
2449
Seritage Growth Properties
SRG
$135M
$310K ﹤0.01%
66,438
-5,600
-8% -$40.6K
ALXO icon
2450
ALX Oncology
ALXO
$272M
$298K ﹤0.01%
49,400
+5,200
+12% +$63.9K

Similar funds

Swiss National Bank's Q2 2024 Portfolio in Review

As of Q2 2024, Swiss National Bank held 2,546 positions worth $146B, up 2% from $143B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Swiss National Bank's Q2 2024 filing shows 41 new, 569 increased, 1,097 reduced and 88 closed positions. Its largest new stake was GE Vernova: 811,465 shares worth $139M. The largest sale was Pioneer Natural Resource Co., an estimated $184M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q2 2024 buy was GE Vernova: 811,465 shares worth $139M.
  • Swiss National Bank added most to ExxonMobil in Q2 2024, an estimated $153M increase.
  • Swiss National Bank's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $135M.
  • Swiss National Bank fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $184M.
  • Swiss National Bank's ten largest holdings make up 33% of its $146B portfolio in Q2 2024.
  • Swiss National Bank opened 41 new positions and closed 88 in Q2 2024.
  • Swiss National Bank's portfolio value rose 2% quarter-over-quarter to $146B.

Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.